Compare MXCT & FGBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MXCT | FGBI |
|---|---|---|
| Founded | 1999 | 1934 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 136.2M | 134.1M |
| IPO Year | 2021 | 2014 |
| Metric | MXCT | FGBI |
|---|---|---|
| Price | $1.24 | $8.37 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $5.50 | N/A |
| AVG Volume (30 Days) | ★ 403.0K | 14.0K |
| Earning Date | 05-12-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 0.44% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.31 |
| Revenue | ★ $33,026,000.00 | N/A |
| Revenue This Year | N/A | $567.70 |
| Revenue Next Year | $18.50 | N/A |
| P/E Ratio | ★ N/A | $27.39 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.64 | $4.31 |
| 52 Week High | $1.86 | $11.02 |
| Indicator | MXCT | FGBI |
|---|---|---|
| Relative Strength Index (RSI) | 49.52 | 50.74 |
| Support Level | $1.19 | $8.24 |
| Resistance Level | $1.30 | $8.86 |
| Average True Range (ATR) | 0.05 | 0.29 |
| MACD | -0.00 | 0.08 |
| Stochastic Oscillator | 54.29 | 72.64 |
MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.
First Guaranty Bancshares Inc provides personalized commercial banking services to its customers in Louisiana through several banking facilities. The company offers commercial real estate loans, commercial and industrial loans, construction and land development loans, agricultural and farmland loans, and, to a lesser extent, consumer and multifamily loans. The company is engaged in a single line of business as a financial institution, which provides a full range of banking, financial, and trust services to state, county, and local government entities, individuals, and small and commercial businesses.